LASN01 / Lassen Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LASN01 / Lassen Therap
NCT06226545: A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Active, not recruiting
2
41
Europe, US
LASN01, Low-dose LASN01, High-dose LASN01, Placebo, Placebo to match
Lassen Therapeutics Inc.
Thyroid Eye Disease, Eye Diseases, Graves Ophthalmopathy, Graves Orbitopathy, Thyroid Associated Ophthalmopathy, Endocrine System Diseases, Orbital Diseases, Proptosis
05/25
01/26
NCT05331300: A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease

Completed
1/2
75
RoW
LASN01, Placebo
Lassen Therapeutics 1 PTY LTD
Pulmonary Fibrosis, Thyroid Eye Disease
11/24
11/24

Download Options